Skip to search formSkip to main contentSkip to account menu

Primary focal hyperhidrosis

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Thoracoscopic sympathicotomy for the treatment of intolerable palmar and axillary hyperhidrosis in children is associated with high recurrence rates
Treatment of palmar and axillary primary focal hyperhidrosis (PFH) in children up to 16 years using thoracoscopic sympathicotomy… 
2020
2020
Heart Rate Variability Assessment and Its Application for Autonomic Function Evaluation in Patients with Hyperhidrosis
Background: Pathophysiology mechanism of primary focal hyperhidrosis (PFHH) is controversial. Heart rate variability (HRV) could… 
2015
2015
Don't Sweat It: Treatment of Adolescent Hyperhidrosis with Botulinum Toxin
Primary focal hyperhidrosis (PFH) affects almost 3% of the U.S. population, and many patients have a positive family history. PFH… 
Review
2001
Review
2001
Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
Muscle cramps may be caused by fluid and salt loss induced by diffuse or focal hyperhidrosis. Recent reports have described the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)